Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-13-018813)

Filing Details

Accession Number:: 0001144204-13-018813
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-03-29 18:45:35
Reporting Period:: 2012-12-31

Filing Date:: 2013-03-29
Accepted Time:: 2013-03-29 18:45:35
Original Submission Date:: 2013-01-03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235007	Endocyte Inc	ECYT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509418	Ron P Ellis	3000 Kent Ave Ste A1-100 West Lafayette IN 47906	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-12-31	6,000	$8.75	31,654	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	75,332	Direct

Footnotes

The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
The reported securities are owned directly by P. Ron Ellis and Margaret Heard Ellis, JTWROS.
The Form 4 is being amended to correct the amount of securities beneficially owned which was incorrectly reported on the original filing.